CAR-T Cellular Immunotherapy Drug and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 CAR-T Cellular Immunotherapy Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global CAR-T Cellular Immunotherapy Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global CAR-T Cellular Immunotherapy Drug Overall Market Size
2.1 Global CAR-T Cellular Immunotherapy Drug Market Size: 2022 VS 2030
2.2 Global CAR-T Cellular Immunotherapy Drug Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top CAR-T Cellular Immunotherapy Drug Players in Global Market
3.2 Top Global CAR-T Cellular Immunotherapy Drug Companies Ranked by Revenue
3.3 Global CAR-T Cellular Immunotherapy Drug Revenue by Companies
3.4 Top 3 and Top 5 CAR-T Cellular Immunotherapy Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies CAR-T Cellular Immunotherapy Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 CAR-T Cellular Immunotherapy Drug Players in Global Market
3.6.1 List of Global Tier 1 CAR-T Cellular Immunotherapy Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 CAR-T Cellular Immunotherapy Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global CAR-T Cellular Immunotherapy Drug Market Size Markets, 2022 & 2030
4.1.2 CD19-Targeted
4.1.3 BCMA-Targeted
4.2 By Type - Global CAR-T Cellular Immunotherapy Drug Revenue & Forecasts
4.2.1 By Type - Global CAR-T Cellular Immunotherapy Drug Revenue, 2018-2023
4.2.2 By Type - Global CAR-T Cellular Immunotherapy Drug Revenue, 2024-2030
4.2.3 By Type - Global CAR-T Cellular Immunotherapy Drug Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global CAR-T Cellular Immunotherapy Drug Market Size, 2022 & 2030
5.1.2 Multiple Myeloma
5.1.3 Non-Hodgkin lymphoma
5.1.4 Leukemia
5.2 By Application - Global CAR-T Cellular Immunotherapy Drug Revenue & Forecasts
5.2.1 By Application - Global CAR-T Cellular Immunotherapy Drug Revenue, 2018-2023
5.2.2 By Application - Global CAR-T Cellular Immunotherapy Drug Revenue, 2024-2030
5.2.3 By Application - Global CAR-T Cellular Immunotherapy Drug Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global CAR-T Cellular Immunotherapy Drug Market Size, 2022 & 2030
6.2 By Region - Global CAR-T Cellular Immunotherapy Drug Revenue & Forecasts
6.2.1 By Region - Global CAR-T Cellular Immunotherapy Drug Revenue, 2018-2023
6.2.2 By Region - Global CAR-T Cellular Immunotherapy Drug Revenue, 2024-2030
6.2.3 By Region - Global CAR-T Cellular Immunotherapy Drug Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America CAR-T Cellular Immunotherapy Drug Revenue, 2018-2030
6.3.2 US CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
6.3.3 Canada CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
6.3.4 Mexico CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe CAR-T Cellular Immunotherapy Drug Revenue, 2018-2030
6.4.2 Germany CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
6.4.3 France CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
6.4.4 U.K. CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
6.4.5 Italy CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
6.4.6 Russia CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
6.4.7 Nordic Countries CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
6.4.8 Benelux CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia CAR-T Cellular Immunotherapy Drug Revenue, 2018-2030
6.5.2 China CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
6.5.3 Japan CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
6.5.4 South Korea CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
6.5.5 Southeast Asia CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
6.5.6 India CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America CAR-T Cellular Immunotherapy Drug Revenue, 2018-2030
6.6.2 Brazil CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
6.6.3 Argentina CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa CAR-T Cellular Immunotherapy Drug Revenue, 2018-2030
6.7.2 Turkey CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
6.7.3 Israel CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
6.7.4 Saudi Arabia CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
6.7.5 UAE CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
7 CAR-T Cellular Immunotherapy Drug Companies Profiles
7.1 Novartis AG
7.1.1 Novartis AG Company Summary
7.1.2 Novartis AG Business Overview
7.1.3 Novartis AG CAR-T Cellular Immunotherapy Drug Major Product Offerings
7.1.4 Novartis AG CAR-T Cellular Immunotherapy Drug Revenue in Global Market (2018-2023)
7.1.5 Novartis AG Key News & Latest Developments
7.2 Kite Pharma
7.2.1 Kite Pharma Company Summary
7.2.2 Kite Pharma Business Overview
7.2.3 Kite Pharma CAR-T Cellular Immunotherapy Drug Major Product Offerings
7.2.4 Kite Pharma CAR-T Cellular Immunotherapy Drug Revenue in Global Market (2018-2023)
7.2.5 Kite Pharma Key News & Latest Developments
7.3 Bristol Myers Squibb
7.3.1 Bristol Myers Squibb Company Summary
7.3.2 Bristol Myers Squibb Business Overview
7.3.3 Bristol Myers Squibb CAR-T Cellular Immunotherapy Drug Major Product Offerings
7.3.4 Bristol Myers Squibb CAR-T Cellular Immunotherapy Drug Revenue in Global Market (2018-2023)
7.3.5 Bristol Myers Squibb Key News & Latest Developments
7.4 Fosun Pharma
7.4.1 Fosun Pharma Company Summary
7.4.2 Fosun Pharma Business Overview
7.4.3 Fosun Pharma CAR-T Cellular Immunotherapy Drug Major Product Offerings
7.4.4 Fosun Pharma CAR-T Cellular Immunotherapy Drug Revenue in Global Market (2018-2023)
7.4.5 Fosun Pharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. CAR-T Cellular Immunotherapy Drug Market Opportunities & Trends in Global Market
Table 2. CAR-T Cellular Immunotherapy Drug Market Drivers in Global Market
Table 3. CAR-T Cellular Immunotherapy Drug Market Restraints in Global Market
Table 4. Key Players of CAR-T Cellular Immunotherapy Drug in Global Market
Table 5. Top CAR-T Cellular Immunotherapy Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global CAR-T Cellular Immunotherapy Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global CAR-T Cellular Immunotherapy Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies CAR-T Cellular Immunotherapy Drug Product Type
Table 9. List of Global Tier 1 CAR-T Cellular Immunotherapy Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CAR-T Cellular Immunotherapy Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - CAR-T Cellular Immunotherapy Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - CAR-T Cellular Immunotherapy Drug Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - CAR-T Cellular Immunotherapy Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - CAR-T Cellular Immunotherapy Drug Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global CAR-T Cellular Immunotherapy Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global CAR-T Cellular Immunotherapy Drug Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2024-2030
Table 30. Novartis AG Company Summary
Table 31. Novartis AG CAR-T Cellular Immunotherapy Drug Product Offerings
Table 32. Novartis AG CAR-T Cellular Immunotherapy Drug Revenue (US$, Mn) & (2018-2023)
Table 33. Novartis AG Key News & Latest Developments
Table 34. Kite Pharma Company Summary
Table 35. Kite Pharma CAR-T Cellular Immunotherapy Drug Product Offerings
Table 36. Kite Pharma CAR-T Cellular Immunotherapy Drug Revenue (US$, Mn) & (2018-2023)
Table 37. Kite Pharma Key News & Latest Developments
Table 38. Bristol Myers Squibb Company Summary
Table 39. Bristol Myers Squibb CAR-T Cellular Immunotherapy Drug Product Offerings
Table 40. Bristol Myers Squibb CAR-T Cellular Immunotherapy Drug Revenue (US$, Mn) & (2018-2023)
Table 41. Bristol Myers Squibb Key News & Latest Developments
Table 42. Fosun Pharma Company Summary
Table 43. Fosun Pharma CAR-T Cellular Immunotherapy Drug Product Offerings
Table 44. Fosun Pharma CAR-T Cellular Immunotherapy Drug Revenue (US$, Mn) & (2018-2023)
Table 45. Fosun Pharma Key News & Latest Developments
List of Figures
Figure 1. CAR-T Cellular Immunotherapy Drug Segment by Type in 2022
Figure 2. CAR-T Cellular Immunotherapy Drug Segment by Application in 2022
Figure 3. Global CAR-T Cellular Immunotherapy Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global CAR-T Cellular Immunotherapy Drug Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global CAR-T Cellular Immunotherapy Drug Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by CAR-T Cellular Immunotherapy Drug Revenue in 2022
Figure 8. By Type - Global CAR-T Cellular Immunotherapy Drug Revenue Market Share, 2018-2030
Figure 9. By Application - Global CAR-T Cellular Immunotherapy Drug Revenue Market Share, 2018-2030
Figure 10. By Type - Global CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global CAR-T Cellular Immunotherapy Drug Revenue Market Share, 2018-2030
Figure 12. By Application - Global CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global CAR-T Cellular Immunotherapy Drug Revenue Market Share, 2018-2030
Figure 14. By Region - Global CAR-T Cellular Immunotherapy Drug Revenue Market Share, 2018-2030
Figure 15. By Country - North America CAR-T Cellular Immunotherapy Drug Revenue Market Share, 2018-2030
Figure 16. US CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 17. Canada CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe CAR-T Cellular Immunotherapy Drug Revenue Market Share, 2018-2030
Figure 20. Germany CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 21. France CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 23. Italy CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 24. Russia CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia CAR-T Cellular Immunotherapy Drug Revenue Market Share, 2018-2030
Figure 28. China CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 29. Japan CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 32. India CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America CAR-T Cellular Immunotherapy Drug Revenue Market Share, 2018-2030
Figure 34. Brazil CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa CAR-T Cellular Immunotherapy Drug Revenue Market Share, 2018-2030
Figure 37. Turkey CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 38. Israel CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 40. UAE CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 41. Novartis AG CAR-T Cellular Immunotherapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Kite Pharma CAR-T Cellular Immunotherapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bristol Myers Squibb CAR-T Cellular Immunotherapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Fosun Pharma CAR-T Cellular Immunotherapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
